| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,595,000 | 3,316,000 | 3,424,000 | 4,373,000 | | Cost of Revenue | 1,214,000 | 1,372,000 | 1,092,000 | 1,061,000 | | | Gross Profit | 2,381,000 | 1,944,000 | 2,332,000 | 3,312,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,094,000 | 768,000 | 1,293,000 | 1,838,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 386,000 | 379,000 | 370,000 | 358,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 901,000 | 797,000 | 669,000 | 1,116,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,000) | (1,000) | (3,000) |
-
| | Earnings Before Interest And Taxes | 900,000 | 796,000 | 666,000 | 1,116,000 | | Interest Expense | 127,000 | 137,000 | 198,000 | 137,000 | | Income Before Tax | 773,000 | 659,000 | 468,000 | 979,000 | | Income Tax Expense | 285,000 | 255,000 | 175,000 | 364,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 488,000 | 404,000 | 293,000 | 615,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 488,000 | 404,000 | 293,000 | 615,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $488,000 | $404,000 | $293,000 | $615,000 |
|
1.52% Nasdaq 0.00%
Income Statement
